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Background: Spontaneous regression of a malignant tumor is the phenomenon of disappearance of cancer cells
without any treatments and it can be induced by an enhanced tumor-targeting immune response. However, there
has not been a comprehensive immunological overview to compare the tumor-regressed lymph nodes and metastatic
lymph nodes in the same patient.
Case presentation: We conducted a histologic analysis of various immune cells in an Asian female patient with
buccal cancer (squamous cell carcinomas), in which the spontaneous regression of metastatic lymphadenopathy was
confirmed by surgical pathology. The immune cell profiles between the metastatic nodes and the tumor-regressed
nodes were compared. Tumor regression was confirmed by hematoxylin & eosin and cytokeratin/Ki-67 staining. Distinct
differences were observed in Foxp3(+) regulatory T (Treg) cells and CD56(+) natural killer (NK) cells; a higher density of
Foxp3(+) Treg cells was found in metastatic lymph nodes and more infiltration of CD56(+) NK cells in tumor regressed
lymph nodes. Other immune cell populations (CD4, CD8, CD20, CD68, CD86, CD123, CD11c, and mannose receptor)
showed no discernible differences in marker expression in the nodes examined.
Conclusion: Less recruitment of Treg and high infiltration of NK cells were key features in tumor-regressed lymph
nodes. Modulation of Treg or NK cells may be a good therapeutic method to control lymph node metastasis.
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Spontaneous regression of a malignant tumor is the pheno-
menon of disappearance of cancer cells without any
treatment [1,2]. Even though this event seems to be rare, it
has been observed for thousands of years [3]. Spontaneous
regressions are known to be related to acute infections,
vaccine therapy, surgical removal of the malignant
tumor and the taking of herbal medicines [4]. And these
phenomena are more common in pediatric embryonal
tumors, and breast and skin cancers [4].
Of note, the immunological characteristics of these
tumors have drawn attention to the main underlying
mechanisms of spontaneous regression. Previous studies
on spontaneous regression have involved investigations
of various immunologic markers for natural killer cells,
macrophages and dendritic cells, that could be involved* Correspondence: hansin.jeong@gmail.com
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However, there has not been a comprehensive immuno-
logical overview comparing lymph node metastasis and
spontaneously regressed metastasis in the lymph nodes
of the same patient. We think it is very important because
the immune cell profiles are quite variable between indi-
vidual hosts, depending upon age [7], hormonal status
[8-10], environmental cues [11], nutrition [12] and even
bio-behavior [13].
Thus, we conducted an immunological study in one
patient with buccal cancer (squamous cell carcinoma), in
which spontaneous regression of metastatic lymphaden-
opathy was confirmed by surgical pathology. We expect
that our study will contribute to the understanding of
the underlying mechanisms of spontaneous regression of
solid cancers, and hopefully, the findings will suggest
new immunological methods of preventing or treating
cancer or corresponding lymph node metastasis.d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Choi et al. BMC Research Notes 2014, 7:293 Page 2 of 6
http://www.biomedcentral.com/1756-0500/7/293Case presentation
Clinical course
A 52-year-old Asian female patient was admitted to our
clinic, with complaints of right cheek pain and an ulcera-
tive protruding mass lesion in the right buccal area. We
conducted punch biopsy for the buccal mass and this
revealed well-differentiated squamous cell carcinoma.
Computed tomography (CT), magnetic resonance imaging
(MRI) and positron emission tomography/computed tom-
ography (PET/CT) were conducted and these delineated a
2.9 × 2 × 1.4 cm buccal mass in the right lower cheek with
right lymph node metastasis (level Ib, IIa and III), and there
was no evidence of distant metastasis. We made a diagnosis
of buccal cancer cT2N2bM0 (Figure 1A-B). She underwent
wide surgical resection of the malignant tumor in the rightFigure 1 Clinical findings and pathology of a tumor-regressed lymph
proved to be a squamous cell carcinoma. (B) Gross photo of the excised p
did not include the left lower neck. (E-F) Pathology view with hematoxylinbuccal area, right comprehensive neck dissection (level I
to V) and left selective neck dissection (level I to III). The
defect that occurred after the tumor resection was recon-
structed with an omental free flap. According to the
pathologic TNM (tumor, node, metastasis) staging system,
the final diagnosis was pT2N1 (right lymph node metasta-
sis). Post-operative adjuvant radiotherapy was adminis-
tered, covering the primary sites and regional nodes (right
whole neck and left upper neck) (Figure 1C-D).
After the treatment mentioned above, we regularly
checked the CT, MRI and PET/CT as scheduled in the
outpatient clinic. During the follow-up period, intermit-
tent swelling of the neck lymph nodes was observed.
Therefore, we performed ultrasonography guided fine
needle aspiration cytology to exclude recurrence, andnode. (A) Ulcero-fungating mass in the right buccal area, which
rimary tumor. (C-D) Radiation fields for adjuvant radiotherapy, which
and eosin staining of the tumor-regressed lymph node.
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has remained in a disease-free state for 4 years. At
post-treatment 4 years 6 months, a markedly enlarged
lymph node in the contralateral lower neck (left level V)
was found. CT and ultrasonography guided fine needle
aspiration cytology showed regional lymph node recur-
rence, which was suggestive of metastatic squamous
cell carcinoma, based on the necrotic features of the
enlarged lymph nodes on the CT and the keratin debris
on cytology (Additional file 1: Figure S1).
Salvage neck dissection was performed for these enlarged
lymph nodes; however, surgical pathology revealed total
regression of metastatic squamous cell carcinoma cells
in the left level V lymph node and there was no evi-
dence of malignancy in the other dissected lymph nodes
(Figure 1E-F). Interestingly, the left level V lymph nodes
were not involved in the previous surgery or radiation
fields. In addition, the patient denied any self-remedy or
other treatments.
Immunohistochemistry findings
To further characterize this rare event, we performed
immunohistochemistry on the various immune cells. TheFigure 2 Immunohistochemical validation of the tumor‐regressed lym
staining. There were no Ki-67(+) proliferating cells around the tumor-regressepatient submitted written informed consent for each
procedure and our Institutional Review Board approved
the use of the archived tissues (Approval No. 2013-08-
088-001). We compared the immune cell profiles among
the metastatic node, non-tumor bearing node (from the
first surgery) and the tumor-regressed nodes (from the
second surgery). The antibodies for staining were cytoker-
atin, Ki-67, CD4, CD8, CD20, CD68, Mannose receptor,
Foxp3, CD56, CD86, CD11c, and CD123 (Additional
file 2: Table S1).
Complete tumor-regression in the lymph node was
confirmed by cytokeratin and Ki-67 staining (Figure 2).
High expression of cytokeratin and Ki-67 levels were ob-
served in the tumor cells in metastatic nodes (Figure 2A,
D), meanwhile cytokeratin expression was noted in the
keratin debris and no Ki-67(+) tumor cells were found
in the tumor-regressed lymph node (Figure 2C,F). In the
tumor-free lymph node, the cytokeratin expression was
not detected (Figure 2B). And most of the cells were
CD86(+) cells with a clump of CD68(+) or CD11c(+) cells
(Additional file 3: Figure S2), suggesting high infiltration
of dendritic cells and macrophages in the tumor-regressed
lymph nodes. However, the distribution of CD4(+), CD8ph node. (A‐C) Cytokeratin AE1/AE3 immunostaining. (D-F) Ki- 67
d remnant keratin debris (Inserts showed higher magnification views).
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genous in the area around the metastatic and regressed
nodes (data not shown).
Marked differences between the metastatic node and
tumor-regressed node were found in the incidence of
Foxp3(+) regulatory T (Treg) cells and CD56(+) natural
killer (NK) cells (Figure 3). There was nearly a two-fold
increase in the density of Foxp3(+) Treg cells in the
metastatic node (Figure 3A), compared with the non-
tumor bearing lymph node (Figure 3B). Meanwhile, very
few Foxp3(+) cells were noted in the tumor-regressed
lymph node (Figure 3C). These findings suggested that
the immune-suppressive microenvironment of Treg
cells could be reversed in the tumor-regressed lymph
node. In addition, a noticeable infiltration of CD56(+)
NK cells was found around the keratin debris in the
tumor-regressed lymph nodes (Figure 3F); however, in
the metastatic and control lymph nodes, the CD56(+)
cell population was negligible (Figure 3D-E). Tumor-
free lymph nodes were negative for cytokeratin, and
had lower expression of Ki-67, Foxp3 and CD56 than
other lymph nodes.Figure 3 Comparison of Foxp3 and CD56 cell distribution. (A-C) Foxp3
the metastatic lymph nodes and more infiltration of CD56(+) NK cells in th
magnification views).Discussion
The purpose of this case report is to compare the differ-
ences of the immune cell profiles between the lymph node
harboring malignant tumor cells and the tumor-regressed
lymph node in the same patient, which possibly occurred
through the rare process of spontaneous regression. Even
though the results could not provide direct evidence of
the underlying mechanisms of the spontaneous regression
of the malignant tumor, our findings may have clinical
significance in that the immune cell profiles according
to the different disease status in the lymph nodes were
analyzed in the same patient. Because the individual
had quite a variable range of immune cell populations,
we believe our data from the single patient may reflect
the change of immunity related to tumor regression more
accurately.
There was a time gap of 4 years 6 months between the
initial and salvage surgery of neck lymph nodes. The
pathology of the salvage surgery revealed total tumor
regression and no viable tumor cells in the lymph nodes
dissected. Thus, transition between tumor and non-tumor
area was not observed in the specimens, suggesting thatstaining. (D-F) CD56 staining. Higher density of Foxp3(+) Treg cells in
e tumor regressed lymph nodes were observed (Inserts showed higher
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undergo total cell-death process due to immunological
events or unknown etiology. Of note, the tumor-regressed
lymph node was located in the contralateral lower neck,
which was not exposed to any treatments, such as surgery
or radiation.
A previous study on the immune response in cervical
intra-epithelial neoplasia with and without spontaneous
regression reported that CD8(+), CD4(+)/CD25(+) cell
ratios and CD138(+) plasma cells were independent pre-
dictors of tumor regression [14]. However, the study did
not evaluate the spatial and temporal changes of the
immune profiles in the patients. Meanwhile, our study
clearly showed a feature of low Treg and high NK cells
in the tumor-regressed lymph node in the same back-
ground of immunity.
There have been many reports supporting the involve-
ment of Treg and NK cells in cancer remission. Treg
cells are well known to play a major role in tumor-driven
immune evasion [15-17]. Thus, there is a high chance
that Treg cells can also exert their effects on tumor
colonization and growth in the metastatic lymph node.
Reciprocally, a decrease of Treg cells was one of the
hallmarks of tumor regression in our study. NK cells are a
subset of cytotoxic cells, important to the maintenance of
innate immunity [18], and they seem to be a main effector
cell for inducing tumor regression. Taken together, the
interaction between Treg and NK cells may be an import-
ant phenomenon in spontaneous tumor regression [19].
However, the differences of immune cell profiles in our
study were not able to be translated into a cause-effect
relationship and the dynamics of tumor regression. For
instance, a huge number of macrophages might infil-
trate into tissues following malignant tumor cell death.
Dendritic cells could accumulate around a regressed
tumor, just after cell antigens had been exposed outside
after cell death. Thus, we have to be very cautious about
the interpretation of these results. Nevertheless, our study
illustrated that Treg and NK cells were the main differ-
ences among various immune cell populations in the
tumor-regressed lymph node, suggesting that they could
modify the tumor microenvironment to suppress tumor
growth and enhance self-arrest of the tumor.
Conclusion
We describe a case of spontaneous malignant tumor
regression in a metastatic lymph node, and through
immunohistochemical analysis of the tumor-regressed
lymph node, reveal the key features of a lower recruit-
ment of Treg cells and a high infiltration of NK cells in
this case of spontaneous regression. Thus, we think that
Treg and NK cells may play a key role in tumor regression,
and additionally, the modulation of Treg cells, as part of
the group of NK cells, may be a good therapeutic methodto control lymph node metastasis. We believe our findings
should be validated through a large cohort and in-depth
mechanistic study.
Consent
Written informed consent was obtained from the patient
for publication of this Case Report and any accompany-
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Additional files
Additional file 1: Figure S1. Pre-surgical evaluation of the tumor-
regressed lymph node. (A-B) CT and US strongly suggest node recurrence
based on the enhancement pattern (white arrow) and irregular internal
echogenicity (mark). (C-D) Aspiration cytology showed tumor recurrence
due to the presence of keratin debris and anucleated squama in the
aspirates (black arrows).
Additional file 2: Table S1. Antibodies used in this study for
immunostaining.
Additional file 3: Figure S2. Staining of dendritic cells and macrophages
in tumor-regressed node. (A) CD86. (B) CD68, (C) CD11c staining. Most
of the cells around the keratin debris were CD86(+) cells with CD68(+)
or CD11c(+) cells, suggesting high infiltration of dendritic cells and
macrophage in the tumor-regressed lymph nodes.
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